These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20358434)

  • 21. Sample size calculation for thorough QT/QTc study considering various factors related to multiple time points.
    Meng Z; Kringle R; Chen X; Zhao PL
    J Biopharm Stat; 2010 May; 20(3):563-77. PubMed ID: 20358436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of several methods for analyzing data from thorough QT studies.
    Tian H; Qiao W; Natarajan J
    J Biopharm Stat; 2010 May; 20(3):632-40. PubMed ID: 20358441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QT interval in normal infants during sleep with concurrent evaluation of QT correction formulae.
    Benatar A; Ramet J; Decraene T; Vandenplas Y
    Med Sci Monit; 2002 May; 8(5):CR351-6. PubMed ID: 12011777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a subject-specific transfer-function-based nonlinear QT interval rate-correction method.
    Jacquemet V; Dubé B; Knight R; Nadeau R; LeBlanc AR; Sturmer M; Becker G; Vinet A; Kuś T
    Physiol Meas; 2011 Jun; 32(6):619-35. PubMed ID: 21493981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnitude of error introduced by application of heart rate correction formulas to the canine QT interval.
    King A; Bailie M; Olivier NB
    Ann Noninvasive Electrocardiol; 2006 Oct; 11(4):289-98. PubMed ID: 17040276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QT interval prolongation and decreased heart rates after intravenous bolus oxytocin injection in male and female conscious rabbits.
    Uzun M; Yapar K; Uzlu E; Citil M; Erdogan HM
    Gen Physiol Biophys; 2007 Sep; 26(3):168-72. PubMed ID: 18063843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statistical models for heart rate correction of the QT interval.
    Ring A
    Stat Med; 2010 Mar; 29(7-8):786-96. PubMed ID: 20213712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statistical consideration in testing for assay sensitivity in a "thorough" QT study.
    Sethuraman V; Wu S; Wang J
    J Biopharm Stat; 2010 May; 20(3):641-53. PubMed ID: 20358442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sample size calculations for crossover thorough QT studies: satisfaction of regulatory threshold and assay sensitivity.
    Anand SP; Murray SC; Koch GG
    J Biopharm Stat; 2010 May; 20(3):587-603. PubMed ID: 20358438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accurate evaluation of QT interval in conscious rhesus monkeys (Macaca mulatta) by use of Holter ECG.
    Hassimoto M; Harada T; Kaga N; Murano H; Obata M
    J Electrocardiol; 2002 Oct; 35(4):333-42. PubMed ID: 12395361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed models for data from thorough QT studies: part 1. assessment of marginal QT prolongation.
    Schall R; Ring A
    Pharm Stat; 2011; 10(3):265-76. PubMed ID: 21574242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the probability of drug-induced QTc-interval prolongation during clinical drug development.
    Chain AS; Krudys KM; Danhof M; Della Pasqua O
    Clin Pharmacol Ther; 2011 Dec; 90(6):867-75. PubMed ID: 22048226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
    Voiculescu M; Ionescu C; Ismail G
    Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical characteristics of moxifloxacin-induced QTc effect.
    Yan LK; Zhang J; Ng MJ; Dang Q
    J Biopharm Stat; 2010 May; 20(3):497-507. PubMed ID: 20358432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QT interval correction in patients with cirrhosis.
    Zambruni A; Di Micoli A; Lubisco A; Domenicali M; Trevisani F; Bernardi M
    J Cardiovasc Electrophysiol; 2007 Jan; 18(1):77-82. PubMed ID: 17229304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statistical issues of QT prolongation assessment based on linear concentration modeling.
    Tsong Y; Shen M; Zhong J; Zhang J
    J Biopharm Stat; 2008; 18(3):564-84. PubMed ID: 18470764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of sevoflurane and desflurane anesthesia on QTc interval and cardiac rhythm in children.
    Aypar E; Karagoz AH; Ozer S; Celiker A; Ocal T
    Paediatr Anaesth; 2007 Jun; 17(6):563-7. PubMed ID: 17498019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart rate correction of the QT duration in rats.
    Kmecova J; Klimas J
    Eur J Pharmacol; 2010 Sep; 641(2-3):187-92. PubMed ID: 20553920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.